Rehmannioside A
CAS No. 81720-05-0
Rehmannioside A( —— )
Catalog No. M19140 CAS No. 81720-05-0
Rehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 140 | In Stock |
|
| 10MG | 211 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRehmannioside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionRehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.
-
DescriptionRehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number81720-05-0
-
Formula Weight524.5
-
Molecular FormulaC21H32O15
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1=CO[C@H]([C@H]2[C@@H]1[C@@H]([C@H]1[C@@]2(O1)CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu C, et al. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J Ethnopharmacol. 2017 Feb 23;198:351-362.
molnova catalog
related products
-
Brentuximab
Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.
-
Varlilumab
Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody with antitumor activity, useful for studying advanced solid tumors.
-
XYLOBIOSE
XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
Cart
sales@molnova.com